Effects of Different Types of Carbohydrates in Snacks and Beverages on Glycemia, Insulinemia and Appetite.
NCT ID: NCT03279107
Last Updated: 2021-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2017-08-25
2020-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Liquid or Solid State of Food on Glycaemia, Lipaemia and Insulinaemia
NCT02875275
The Dose Effects of Isomaltulose and Sucrose on Glycaemic and Insulinemic Response
NCT04653207
The Effect of a Carbohydrate Drink on Cognitive Function and Exercise Performance
NCT02045342
Liquid Protein Preloads With Different Carbohydrate Types Effects on the Glycaemic and Insulinaemic Response
NCT02151188
The Acute Effect of Malt Extract Versus Sucrose on the Response of Glucose and Insulin, Subjective Appetite Sensations and ad Libitum Energy Intake
NCT01615081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control beverage with glucose powder
Standard glucose beverage with 50 g of glucose powder
No interventions assigned to this group
Beverage with soluble corn fiber
Beverage with soluble corn fiber (50 gram of total carbohydrate)
Soluble corn fiber
soluble corn fiber
Beverage with maltodextrin
Beverage with maltodextrin (50 gram of total carbohydrate)
maltodextrin
maltodextrin
Snack with soluble corn fiber
snack with soluble corn fiber (50 gram of total carbohydrate)
Soluble corn fiber
soluble corn fiber
Snack with maltodextrin
Snack with maltodextrin (50 gram of total carbohydrate)
maltodextrin
maltodextrin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Soluble corn fiber
soluble corn fiber
maltodextrin
maltodextrin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Either one of the three criteria:
* Normal weight (body mass index 18.5-22.9 kg/m2) and Fasting Blood Glucose 5.0-6.0mmol/L
* Overweight (body mass index 23.0 - 30.0 kg/m2) and Fasting Blood Glucose 5.0-6.0mmol/L
* Overweight (body mass index 23.0 - 30.0 kg/m2) and Fasting Blood Glucose \<5.0mmol/L
Exclusion Criteria
* Have any metabolic diseases (such as diabetes, hypertension etc)
* Have known glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency)
* Have medical conditions and/or taking medications known to affect glycemia (glucocorticoids, thyroid hormones, thiazide diuretics)
* Have any major organ dysfunction (e.g. cardiovascular, respiratory, hepatic, renal, gastrointestinal) that may influence taste, olfaction, appetite, digestion, metabolism, absorption or elimination of test foods, nutraceutical or drug
* Consume fiber supplements or other supplements that is likely to interfere with study outcomes
* Have any severe food allergy (e.g. anaphylaxis to peanuts)
* Have any known allergies to any food components of the study protocol
* Have active Tuberculosis (TB) or currently receiving treatment for TB
* Have any known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV)
* Is a study team member or an immediate family of any study team member. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted.
* Is enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study of the CNRC.
* Partake in sports at the competitive and/or endurance levels
* Intentionally restrict food intake
* Have poor veins impeding venous access
* Have any history of severe vasovagal syncope (blackouts or near faints) following blood draws
21 Years
60 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tate and Lyle Ingredients France
INDUSTRY
JeyaKumar Henry
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
JeyaKumar Henry
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Nutrition Research Centre
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/00428
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.